BFRI
#4522
Biofrontera Inc. - Common Stock
1.5 6 USD
+0.05%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+4.70%
Monthly Change
+39.29%
6 month change
+65.96%
Year Change
+79.31%
Previous Close
1.4 9
Open
1.5 8
Low
1.5 6
High
1.5 9
Volume
73
Financials
- Market Capitalization 23.17 M
- Employee 94
- Founded 2015
- CEO N/A
- Website www.biofrontera-us.com
- Headquarter Delaware, United States
- FIGI BBG00HTD0PX0
- Industry Drug Manufacturers—Specialty & Generic
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.55
Price to sales ratio
0.14
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4489 |  TXMD TherapeuticsMD, Inc. - Common Stock | 2.24 USD | +0.90% | +9.27% | +8.21% | +103.64% | 25.93 M USD | ||
| 4506 |  AYTU Aytu BioPharma, Inc. - Common Stock | 2.30 USD | +2.68% | -2.13% | +6.48% | -2.13% | 24.69 M USD | ||
| 4823 |  AKAN Akanda Corp. - Common Shares | 4.03 USD | -4.73% | +4.95% | -32.83% | +2.54% | 7.99 M USD | ||
| 4871 |  SNOA Sonoma Pharmaceuticals, Inc. - Common Stock | 1.32 USD | -0.75% | -2.22% | +11.86% | -52.35% | 6.32 M USD |
Frequently asked questions about Biofrontera Inc. Common Stock
What is the Biofrontera Inc. Common Stock stock price today?
The current price of Biofrontera Inc. Common Stock (BFRI) is 1.56. Over the past 24 hours, the stock has changed by +4.70%. Follow the BFRI chart for real-time price dynamics.
What is the stock ticker of Biofrontera Inc. Common Stock?
Biofrontera Inc. Common Stock trades under the ticker BFRI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Biofrontera Inc. Common Stock stock going up?
BFRI has changed by +6.12% over the last week, +39.29% over the last month, and +79.31% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Biofrontera Inc. Common Stock?
Biofrontera Inc. Common Stock currently has a market capitalization of 23.17 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Biofrontera Inc. Common Stock earnings last quarter?
Last quarter, Biofrontera Inc. Common Stock reported earnings of -0.05 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Biofrontera Inc. Common Stock revenue for the last quarter?
Biofrontera Inc. Common Stock reported quarterly revenue of 12 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Biofrontera Inc. Common Stock net income for the last quarter?
Biofrontera Inc. Common Stock reported net income of -604 K for the last quarter. The previous quarter showed -4.75 M, which means net income changed by +87.29%.
How many employees does Biofrontera Inc. Common Stock have?
As of the latest available data, Biofrontera Inc. Common Stock has 94 employees. Workforce size can provide additional context about the company's scale and operations.
What is Biofrontera Inc. Common Stock EBITDA?
Biofrontera Inc. Common Stock EBITDA is -459 K, and its EBITDA margin is -3.82%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Biofrontera Inc. Common Stock stock?
You can buy Biofrontera Inc. Common Stock (BFRI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Biofrontera Inc. Common Stock stock?
Investing in Biofrontera Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BFRI chart and related analysis on metatrader.com as part of your research.